HOB Biotech Group Corp.,Ltd (SHA:688656)
158.55
+4.35 (2.82%)
Sep 30, 2025, 3:00 PM CST
SHA:688656 Revenue
HOB Biotech Group Corp.,Ltd had revenue of 112.05M CNY in the quarter ending June 30, 2025, a decrease of -4.40%. This brings the company's revenue in the last twelve months to 389.19M, down -4.30% year-over-year. In the year 2024, HOB Biotech Group Corp.,Ltd had annual revenue of 402.34M with 2.01% growth.
Revenue (ttm)
389.19M
Revenue Growth
-4.30%
P/S Ratio
25.53
Revenue / Employee
742.73K
Employees
529
Market Cap
9.94B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 402.34M | 7.93M | 2.01% |
Dec 31, 2023 | 394.41M | 74.01M | 23.10% |
Dec 31, 2022 | 320.39M | 2.68M | 0.84% |
Dec 31, 2021 | 317.71M | 95.85M | 43.20% |
Dec 31, 2020 | 221.86M | -37.27M | -14.38% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Shanghai United Imaging Healthcare | 10.98B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |